# iBio Reports Q3 Fiscal Year 2026 Financial Results and Provides Corporate Update
Canonical URL: https://biopharmsignal.com/news/IBIO/ibio-reports-q3-fiscal-year-2026-financial-results-and-provides-corporate-update
Ticker: IBIO
Company: Ibio Inc
Source: Ibio Inc
Published: 2026-05-12 20:05 EST
Original Source URL: https://ir.ibioinc.com
## Article Body
No article body is available yet.
## Recent Company News
- 2026-07-01 11:00 EST — [iBio Reports Single Dose of IBIO-610 Achieved Near-Complete Active Activin E Inhibition Through Eight Weeks in Obese NHP Study](https://biopharmsignal.com/news/IBIO/ibio-reports-single-dose-of-ibio-610-achieved-near-complete-active-activin-e-inh-15c14063) — Source: Ibio Inc
- 2026-06-02 20:01 EST — [iBio to Participate in Upcoming Healthcare Investor Conferences](https://biopharmsignal.com/news/IBIO/ibio-to-participate-in-upcoming-healthcare-investor-conferences) — Source: Ibio Inc
- 2026-06-02 11:00 EST — [iBio Becomes a Clinical-Stage Company with First Participant Dosed in Phase 1 Clinical Trial of IBIO-600 in Adults with Obesity](https://biopharmsignal.com/news/IBIO/ibio-becomes-a-clinical-stage-company-with-first-participant-dosed-in-phase-1-clinical-trial-of-ibio-600-in-adults-with-obesity) — Source: Ibio Inc
- 2026-05-12 20:05 EST — [iBio Reports Q3 Fiscal Year 2026 Financial Results and Provides Corporate Update](https://biopharmsignal.com/news/IBIO/ibio-reports-q3-fiscal-year-2026-financial-results-and-provides-corporate-update) — Source: Ibio Inc
- 2026-05-08 11:15 EST — [iBio Appoints Distinguished Biotech Leader, Elizabeth Stoner, to its Board of Directors](https://biopharmsignal.com/news/IBIO/ibio-appoints-distinguished-biotech-leader-elizabeth-stoner-to-its-board-of-directors) — Source: Ibio Inc
## Related News
- 2026-07-22 20:15 EST — BFRG — [BullFrog AI to Participate in the BTIG Virtual Biotechnology Conference](https://biopharmsignal.com/news/BFRG/bullfrog-ai-to-participate-in-the-btig-virtual-biotechnology-conference-5880a10e)
- 2026-07-22 20:05 EST — AZTA — [Azenta Announces Fiscal 2026 Third Quarter Conference Call and Webcast](https://biopharmsignal.com/news/AZTA/azenta-announces-fiscal-2026-third-quarter-conference-call-and-webcast-48419fff)
- 2026-07-22 20:05 EST — VKTX — [Viking Therapeutics to Report Financial Results for Second Quarter 2026 on July 29, 2026](https://biopharmsignal.com/news/VKTX/viking-therapeutics-to-report-financial-results-for-second-quarter-2026-on-july--bbf2553f)
- 2026-07-22 20:01 EST — AXON — [Axon to Release Second Quarter 2026 Earnings on August 5, 2026](https://biopharmsignal.com/news/AXON/axon-to-release-second-quarter-2026-earnings-on-august-5-2026-66120902)
- 2026-07-22 12:39 EST — ARTL — [New Analysis of Over 50 Studies Showed that All the Non-Prescription CBD Products Researched Fell Short of Therapeutic Efficacy — Reinforcing the Case for Artelo's Optimized ART12.11 CBD Composition](https://biopharmsignal.com/news/ARTL/new-analysis-of-over-50-studies-showed-that-all-the-non-prescription-cbd-product-a3445432)